QSAR analysis of the effects of OATP1B1 transporter by structurally diverse natural products using a particle swarm optimization-combined multiple linear regression approach

Chemometrics and Intelligent Laboratory Systems

Volumn 130, Issue , 2014, Pages 84-90

  Cao, Dong Sheng ^a,b   Liu, Shao ^a   Fan, Lan ^b   Liang, Yi Zeng ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Drug nature product interaction; Natural products; OATP1B1 transporter; Particle swarm optimization based multiple linear regression (PSO MLR); Quantitative structure activity relationship (QSAR)

Indexed keywords

ARTEMISIN; AURANTIIN; BAICALEIN; BAICALIN; BERBERINE; CHRYSIN; COUMARIN; CRYPTOTANSHINONE; CURCUMIN; ECHINACOSIDE; EPIGALLOCATECHIN GALLATE; ESTRONE SULFATE; EVODIAMINE; GENISTEIN; GENISTIN; HESPERETIN; HONOKIOL; ISOQUERCITRIN; MAGNOLOL; NARINGENIN; NATURAL PRODUCT; ORGANIC ANION TRANSPORTER 1; PIPERINE; PROTEIN OATP1B1; QUERCITRIN; SALIDROSIDE; TANSHINONE I; TANSHINONE IIA; TAXIFOLIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANALYTIC METHOD; ANALYTICAL ERROR; ARTICLE; AUTOANALYSIS; COMPUTER PROGRAM; CORRELATION COEFFICIENT; DRUG SCREENING; DRUG STRUCTURE; EXPERIMENTAL MODEL; IC 50; MEASUREMENT ACCURACY; MOLECULAR INTERACTION; MULTIPLE LINEAR REGRESSION ANALYSIS; PARTICLE SWARM OPTIMIZATION BASED MULTIPLE LINEAR REGRESSION METHOD; PREDICTION; PRIORITY JOURNAL; PROTEIN STRUCTURE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; VALIDATION STUDY;

EID: 84887544077     PISSN: 01697439     EISSN: 18733239     Source Type: Journal    
DOI: 10.1016/j.chemolab.2013.10.011     Document Type: Article

References (25)

1. Gao B., Hagenbuch B., Kullak-Ublick G.A., Benke D., Aguzzi A., Meier P.J. J. Pharmacol. Exp. Ther. 2000, 294:73-79.
2. Tamai I., Nezu J.-i., Uchino H., Sai Y., Oku A., Shimane M., Tsuji A. Biochem. Biophys. Res. Commun. 2000, 273:251-260.
3. Cvetkovic M., Leake B., Fromm M.F., Wilkinson G.R., Kim R.B. Drug Metab. Dispos. 1999, 27:866-871.
4. Niemi M., Pasanen M.K., Neuvonen P.J. Pharmacol. Rev. 2011, 63:157-181.
5. van der Deure W.M., Friesema E.C.H., de Jong F.J., de Rijke Y.B., de Jong F.H., Uitterlinden A.G., Breteler M.M.B., Peeters R.P., Visser T.J. Endocrinology 2008, 149:4695-4701.
6. Tian L., Liu H., Xie S., Jiang J., Han L., Huang Y., Li Y. Clin. Ther. 2011, 33:655-663.
7. Campbell S.D., Lau W.F., Xu J.J. Chem. Biol. Interact. 2009, 182:45-51.
8. Dallas B. Anal. Biochem. 2010, 405:50-58.
9. Hirano M., Maeda K., Shitara Y., Sugiyama Y. Drug Metab. Dispos. 2006, 34:1229-1236.
10. Shitara Y., Sato H., Sugiyama Y. Annu. Rev. Pharmacol. Toxicol. 2005, 45:689-723.
11. Petitet F., Barberan O., Dubus E., Ijjaali I., Donlan M., Ollivier S., Michel A. Expert Opin. Drug Discovery 2006, 1:737-751.
12. Zhang L., Zhang Y., Zhao P., Huang S.-M. AAPS J. 2009, 11:300-306.
13. Bachmann K.A., Lewis J.D. Ann. Pharmacother. 2005, 39:1064-1072.
14. Jiunn H L. Adv. Drug Deliv. Rev. 2003, 55:53-81.
15. Wu Lan-xiang, Guo Cheng-xian, Qiang Qu J.Y., Chen Wang-qing, Wang Guo, Fan Lan, Li Qing, Zhang Wei, Zhou H.-h. Xenobiotica 2012, 42:339-348.
16. Poli R., Kennedy J., Blackwell T. Swarm Intell. 2007, 1:33-57.
17. Shen Q., Jiang J.-H., Jiao C.-X., Shen G.-l., Yu R.-Q. Eur. J. Pharm. Sci. 2004, 22:145-152.
18. Tang L.-J., Zhou Y.-P., Jiang J.-H., Zou H.-Y., Wu H.-L., Shen G.-L., Yu R.-Q. J. Chem. Inf. Model. 2007, 47:1438-1445.
19. Hu L., Wu H., Lin W., Jiang J., Yu R. QSAR Comb. Sci. 2007, 26:92-101.
20. Rucker C., Rucker G., Meringer M. J. Chem. Inf. Model. 2007, 47:2345-2357.
21. Applied Linear Regression Models 2005, Higher Education Press. Kutner, Nachtsheim, Neter (Eds.).
22. Cao D.-S., Liang Y.-Z., Xu Q.-S., Li H.-D., Chen X. J. Comput. Chem. 2010, 31:592-602.
23. Cao D., Liang Y., Xu Q., Yun Y., Li H. J. Comput. Aided Mol. Des. 2011, 25:67-80.
24. Dimitrov S., Dimitrova G., Pavlov T., Dimitrova N., Patlewicz G., Niemela J., Mekenyan O. J. Chem. Inf. Model. 2005, 45:839-849.
25. Dragos H., Gilles M., Alexandre V. J. Chem. Inf. Model. 2009, 49:1762-1776.